Literature DB >> 6419855

Penicillamine induced myasthenia reactivated by gold.

A P Moore, A C Williams, P Hillenbrand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6419855      PMCID: PMC1444547          DOI: 10.1136/bmj.288.6412.192-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Deficient sulphoxidation status and D-penicillamine toxicity.

Authors:  G S Panayi; G Huston; R R Shah; S C Mitchell; J R Idle; R L Smith; R H Waring
Journal:  Lancet       Date:  1983-02-19       Impact factor: 79.321

2.  Influence of previous gold toxicity on subsequent development of penicillamine toxicity.

Authors:  P J Smith; W R Swinburn; D R Swinson; I M Stewart
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

3.  Does the order of second-line treatment in rheumatoid arthritis matter?

Authors:  M M Steven; J A Hunter; R M Murdoch; H A Capell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

4.  Ptosis and weakness after start of D-penicillamine therapy.

Authors:  S G Atcheson; J R Ward
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

5.  Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor.

Authors:  C T Bever; H W Chang; A S Penn; I A Jaffe; E Bock
Journal:  Neurology       Date:  1982-10       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.